Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

10 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Combination of disease-modifying antirheumatic drugs in the treatment of rheumatoid arthritis. A survey of Alabama rheumatologists.
Baum SK, Tracy IC, Henderson EH, Alarcón GS. Baum SK, et al. Among authors: tracy ic. Arthritis Care Res. 1991 Mar;4(1):48-51. doi: 10.1002/art.1790040109. Arthritis Care Res. 1991. PMID: 11188587
Survival and drug discontinuation analyses in a large cohort of methotrexate treated rheumatoid arthritis patients.
Alarcón GS, Tracy IC, Strand GM, Singh K, Macaluso M. Alarcón GS, et al. Among authors: tracy ic. Ann Rheum Dis. 1995 Sep;54(9):708-12. doi: 10.1136/ard.54.9.708. Ann Rheum Dis. 1995. PMID: 7495340 Free PMC article.
Type C TP53-CDKN1A pathway dysfunction occurs independently of CDKN1A gene polymorphisms in chronic lymphocytic leukaemia and is associated with TP53 abnormalities.
Tracy I, Tapper W, Parker A, Gardiner A, Sadullah S, Pratt G, Copplestone A, Oscier D, Best OG. Tracy I, et al. Br J Haematol. 2017 Sep;178(5):824-826. doi: 10.1111/bjh.14172. Epub 2016 Jun 13. Br J Haematol. 2017. PMID: 27292869 No abstract available.
A new minimal deleted region at 11q22.3 reveals the importance of interpretation of diminished FISH signals and the choice of probe for ATM deletion screening in chronic lymphocytic leukemia.
Gardiner A, Parker H, Glide S, Mould S, Robinson H, Tracy I, Stankovic T, Oscier D, Strefford J. Gardiner A, et al. Leuk Res. 2012 Mar;36(3):307-10. doi: 10.1016/j.leukres.2011.08.002. Epub 2011 Sep 28. Leuk Res. 2012. PMID: 21955805
Defining the prognosis of early stage chronic lymphocytic leukaemia patients.
Pepper C, Majid A, Lin TT, Hewamana S, Pratt G, Walewska R, Gesk S, Siebert R, Wagner S, Kennedy B, Miall F, Davis ZA, Tracy I, Gardiner AC, Brennan P, Hills RK, Dyer MJ, Oscier D, Fegan C. Pepper C, et al. Br J Haematol. 2012 Feb;156(4):499-507. doi: 10.1111/j.1365-2141.2011.08974.x. Epub 2011 Dec 15. Br J Haematol. 2012. PMID: 22171799
The frequency of TP53 gene defects differs between chronic lymphocytic leukaemia subgroups harbouring distinct antigen receptors.
Malcikova J, Stalika E, Davis Z, Plevova K, Trbusek M, Mansouri L, Scarfò L, Baliakas P, Gardiner A, Sutton LA, Francova HS, Agathangelidis A, Anagnostopoulos A, Tracy I, Makris A, Smardova J, Ghia P, Belessi C, Gonzalez D, Rosenquist R, Oscier D, Pospisilova S, Stamatopoulos K. Malcikova J, et al. Br J Haematol. 2014 Aug;166(4):621-5. doi: 10.1111/bjh.12893. Epub 2014 Apr 12. Br J Haematol. 2014. PMID: 24725250 No abstract available.
A subset of Binet stage A CLL patients with TP53 abnormalities and mutated IGHV genes have stable disease.
Best OG, Gardiner AC, Davis ZA, Tracy I, Ibbotson RE, Majid A, Dyer MJ, Oscier DG. Best OG, et al. Leukemia. 2009 Jan;23(1):212-4. doi: 10.1038/leu.2008.260. Epub 2008 Sep 25. Leukemia. 2009. PMID: 18818700 No abstract available.
TP53 mutation profile in chronic lymphocytic leukemia: evidence for a disease specific profile from a comprehensive analysis of 268 mutations.
Zenz T, Vollmer D, Trbusek M, Smardova J, Benner A, Soussi T, Helfrich H, Heuberger M, Hoth P, Fuge M, Denzel T, Häbe S, Malcikova J, Kuglik P, Truong S, Patten N, Wu L, Oscier D, Ibbotson R, Gardiner A, Tracy I, Lin K, Pettitt A, Pospisilova S, Mayer J, Hallek M, Döhner H, Stilgenbauer S; European Research Initiative on CLL (ERIC). Zenz T, et al. Leukemia. 2010 Dec;24(12):2072-9. doi: 10.1038/leu.2010.208. Epub 2010 Sep 23. Leukemia. 2010. PMID: 20861914